10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference

Rhea-AI Summary

10x Genomics (Nasdaq: TXG), a leader in life sciences, announced its participation in the 43rd Annual Cowen Healthcare Conference in Boston, Massachusetts, scheduled for March 6, 2023, at 11:10 a.m. Eastern Time. The management team will engage in a fireside chat, which will be accessible via a live webcast on the company’s investors page.

10x Genomics specializes in developing technology to analyze complex biological systems, with a broad patent portfolio and products used by top global research institutions and pharmaceutical companies.

News Market Reaction – TXG

-1.76%

-1.76% Session move

In the trading session that priced this news, TXG declined 1.76%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLEASANTON, Calif., Feb. 22, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be participating in the upcoming 43^rd Annual Cowen Healthcare Conference in Boston, Massachusetts.

10x Genomics' management is scheduled to participate in a fireside chat on Monday, March 6, at 11:10 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at: https://investors.10xgenomics.com/.

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2021 based on publications and all of the top 20 global pharmaceutical companies by 2021 research and development spend and have been cited in over 4,500 research papers on discoveries ranging from oncology to immunology and neuroscience. Our patent portfolio comprises more than 1,750 issued patents and patent applications.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts

Investors: investors@10xgenomics.com

Media: media@10xgenomics.com

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-43rd-annual-cowen-healthcare-conference-301753642.html

SOURCE 10x Genomics, Inc.

FAQ

When will 10x Genomics present at the Cowen Healthcare Conference?

10x Genomics will present at the Cowen Healthcare Conference on March 6, 2023, at 11:10 a.m. Eastern Time.

How can I watch the 10x Genomics presentation at the Cowen Healthcare Conference?

You can access the live and archived webcast of the 10x Genomics presentation on their investors page at https://investors.10xgenomics.com.

What is the focus of 10x Genomics?

10x Genomics focuses on mastering biology to advance human health through innovative life science technologies.

What type of products does 10x Genomics offer?

10x Genomics offers instruments, consumables, and software for analyzing biological systems with high resolution and scale.

Where is 10x Genomics based?

10x Genomics is based in Pleasanton, California.